Skip to main content

Table 1 Mean utility values for UK general public (N = 89).

From: Population preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility study

Health State

Mean ± SD

95% CI (lower, upper)

Toxicity disutility

Complete Response

0.91 ± 0.11

0.88, 0.93

NA

Partial Response

0.84 ± 0.14

0.81, 0.87

NA

No Change

0.78 ± 0.14

0.75, 0.82

NA

NC + 1-2 Nausea

0.73 ± 0.17

0.69, 0.76

-0.05 (0.02)

NC + 1-2 Nausea/Vomiting

0.73 ± 0.16

0.69, 0.76

-0.05 (0.02)

Second-line Treatment

0.71 ± 0.17

0.68, 0.75

NA

NC + 1-2 Diarrhea

0.70 ± 0.19

0.66, 0.74

-0.08 (0.02)

NC + 3-4 Anemia

0.69 ± 0.18

0.65, 0.72

-0.09 (0.02)

Progressive Disease

0.68 ± 0.20

0.64, 0.72

NA

NC + 3-4 Pyrexia

0.67 ± 0.17

0.63, 0.70

-0.11 (0.02)

Third-line Treatment

0.65 ± 0.22

0.60, 0.69

NA

NC + 3-4 Pneumonia

0.58 ± 0.19

0.54, 0.62

-0.20 (0.02)